New suspicious lesions on breast MRI in neoadjuvant therapy
According to ARRS' American Journal of Roentgenology (AJR), new suspicious findings occurred in 5.5% of breast MRI examinations performed to monitor response to neoadjuvant therapy; none of these new lesions were malignant.
Jan 14, 2021
0
5
